ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY

Gopalaswamy Vinaya; Dhibar Deba Prasad; Gupta Vipin; Arya Ashutosh Kumar; Khandelwal Niranjan; Bhansali Anil; Garg Sudhir Kumar; Agarwal Neelam; Rao Sudhaker D.; Bhadada Sanjay Kumar

首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY

【24h】

ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY

机译：经细菌骨质疏松症的一周Teriparatide治疗的合成代谢骨窗：试验研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: Osteoporosis is a major public health problem that reduces bone strength and increases fracture risk. Teriparatide is an established and the only currently available anabolic therapy for the treatment of postmenopausal osteoporosis (PMO) with a recommended daily dose of 20 mu g given subcutaneously. However, there are limited data regarding the long-term effect of once-weekly teriparatide therapy on bone mineral density (BMD), bone turnover markers (BTMs), and anabolic bone window.

机译：目的：骨质疏松症是一种主要的公共卫生问题，可降低骨骼强度并提高骨折风险。 Teriparatide是一种确定的，目前可获得的合成代谢疗法，用于治疗绝经后骨质疏松症（PMO），其推荐的每日剂量为20μg皮下给药。然而，关于骨矿物密度（BMD），骨质周转标记（BTMS）和合成代谢骨窗口的一次每周Teriparatide治疗的长期效果有限。

著录项

来源
《Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists》 |2017年第6期|共5页
作者
Gopalaswamy Vinaya; Dhibar Deba Prasad; Gupta Vipin; Arya Ashutosh Kumar; Khandelwal Niranjan; Bhansali Anil; Garg Sudhir Kumar; Agarwal Neelam; Rao Sudhaker D.; Bhadada Sanjay Kumar;
展开▼
作者单位

PGIMER Dept Internal Med Chandigarh India;

PGIMER Dept Internal Med Chandigarh India;

PGIMER Dept Internal Med Chandigarh India;

PGIMER Dept Endocrinol Chandigarh India;

PGIMER Dept Radio Diag &

Imaging Chandigarh India;

PGIMER Dept Endocrinol Chandigarh India;

GMCH Dept Orthopaed Chandigarh India;

PGIMER Dept OBG Chandigarh India;

Henry Ford Hlth Syst Bone &

Mineral Res Lab Detroit MI USA;

PGIMER Dept Endocrinol Chandigarh India;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY [J] . Gopalaswamy Vinaya, Dhibar Deba Prasad, Gupta Vipin, Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2017,第6期

机译：经细菌骨质疏松症的一周Teriparatide治疗的合成代谢骨窗：试验研究
2. ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS [J] . Mechanick Jeffrey I., Hurley Daniel L., Garvey W. Timothy Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2017,第6期

机译：一周术后骨质疏松症的一周Teriparatide治疗的合成代谢骨窗
3. ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS [J] . Abate Ejigayehu G. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2017,第6期

机译：一周术后骨质疏松症的一周Teriparatide治疗的合成代谢骨窗
4. Spatial analysis of the degree and distribution of bone mineralization in relation to anabolic and anti-resorptive agents used for osteoporosis treatment [C] . G.M. Campbell, R. Bernhardt, D. Scharnweber, European conference on biomaterials;ESB 2010 . 2010

机译：与用于骨质疏松症治疗的合成代谢和抗吸收剂有关的骨矿化程度和分布的空间分析
5. Once-weekly teriparatide treatment prevents microdamage accumulation in the lumbar vertebral trabecular bone of ovariectomized cynomolgus monkeys [D] . 吉武新悟 2019

机译：每周一次特立帕肽治疗可防止卵巢切除的食蟹猴的腰椎小梁骨中的微损伤积累
6. Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis [O] . T. Sugimoto, T. Nakamura, Y. Nakamura, -1

机译：绝经后骨质疏松妇女每周服用特立帕肽24周期间骨转换标志物变化的概况
7. Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis [O] . T. Sugimoto, T. Nakamura, Y. Nakamura, 2013

机译：绝经后骨质疏松妇女每周服用特立帕肽24周期间骨转换标志物变化的概况

ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY

摘要

著录项

相似文献

相关主题

期刊订阅